PerkinElmer, Inc. (PKI): Price and Financial Metrics
PerkinElmer, Inc. (PKI)
Today's Latest Price: $70.83 USD
Updated Apr 1 4:10pm
Add PKI to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 132 in Medical - Devices & Equipment
See all "A" rated Strong Buy stocks
PKI Stock Summary
- With a one year PEG ratio of 313.22, Perkinelmer Inc is expected to have a higher PEG ratio (a measure of how expensive a stock is relative to its expected earnings growth) than 90.28% of US stocks.
- PKI's went public 34.27 years ago, making it older than 92.67% of listed US stocks we're tracking.
- The price/operating cash flow metric for Perkinelmer Inc is higher than 88.05% of stocks in our set with a positive cash flow.
- Stocks that are quantitatively similar to PKI, based on their financial statements, market capitalization, and price volatility, are GNRC, CW, MSA, HRC, and HUN.
- PKI's SEC filings can be seen here. And to visit Perkinelmer Inc's official web site, go to www.perkinelmer.com.
PKI Stock Price Chart More Charts
PKI Price/Volume Stats
| Current price | $70.83 | 52-week high | $103.00 |
| Prev. close | $75.28 | 52-week low | $62.91 |
| Day low | $69.60 | Volume | 1,249,233 |
| Day high | $73.11 | Avg. volume | 833,718 |
| 50-day MA | $85.50 | Dividend yield | 0.37% |
| 200-day MA | $88.72 | Market Cap | 7.88B |
PerkinElmer, Inc. (PKI) Company Bio
PerkinElmer Inc. provides products, services, and solutions to the diagnostics, research, environmental, industrial, and laboratory services markets worldwide. The company operates through two segments, Human Health and Environmental Health. The company was founded in 1931 and is based in Waltham, Massachusetts.
PKI Price Forecast Based on DCF Valuation
| Current Price | DCF Fair Value Target: | Forecasted Gain: |
| $70.83 | $28.14 | -63% |
Below please find a table outlining a discounted cash flow forecast for PKI, in which we model out valuation assuming a variety of terminal growth rates. To summarize, we found that Perkinelmer Inc ranked in the 19th percentile in terms of potential gain offered. We should note, though, that the most conservative analysis suggests this stock will yield negative results -- and thus may be a potential short opportunity. As for the metrics that stood out in our discounted cash flow analysis of Perkinelmer Inc, consider:
- 79% of the company's capital comes from equity, which is greater than 64.2% of stocks in our cash flow based forecasting set.
- The weighted average cost of capital for the company is 7. This value is greater than just 20.46% stocks in the Healthcare sector that generate free cash flow.
| Terminal Growth Rate in Free Cash Flow | Return Relative to Current Share Price |
| 0% | -63% |
| 1% | -63% |
| 2% | -63% |
| 3% | -62% |
| 4% | -62% |
| 5% | -62% |
DHR, HAE, PPD, AZN, and CNC can be thought of as valuation peers to PKI, in the sense that they are in the Healthcare sector and have a similar price forecast based on DCF valuation.
Top Stories View All
5 Fitness Stocks for the “Modern World”
How Should Cannabis Investors Interpret Cronos Group's Earnings Report?
3 Reasons for Economic Hope in a Sea of Darkness
NYSE Suspends Trading for CannTrust (CTST) and Commences Delisting Process
Best & Worst Performing Stock Industries for March 31, 2020
View All Top Stories
Loading social stream, please wait...